Active	Status	Sponsor type	Region	Phase	Filter
11 Active 3 Inactive 14 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

11 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Falavigna, Maicon
NCT05052307: A Real-world Evidence Study of BNT162b2 mRNA Covid-19 Vaccine in Brazil	Completed	N/A	4574	RoW	Pfizer/BioNTech BNT162b2 mRNA COVID-19 vaccine, CoronaVac COVID-19 vaccine, ChAdOx1 nCoV-19 Covid-19 Vaccine, Ad26.COV2.S COVID-19 Vaccine	Hospital Moinhos de Vento, Universidade Federal do Paraná, Pfizer, Inova Medical	Covid19	06/22	07/23
NCT05403307: A Real-world Evidence Study of BNT162b2 mRNA Covid-19 Vaccine Among Children in Brazil	Completed	N/A	757	RoW	Pfizer/BioNTech BNT162b2 mRNA COVID-19 vaccine, CoronaVac COVID-19 vaccine	Hospital Moinhos de Vento, Universidade Federal do Paraná, Pfizer, Inova Medical	COVID-19	04/23	07/23
NCT05822193: Incidence, Associated Factors, and Burden of Post COVID-19 Condition in Brazil	Recruiting	N/A	1694	RoW	Multiple exposures	Inova Medical, Merck Sharp & Dohme LLC	Post-Acute COVID-19 Syndrome	03/24	03/24
Rosa, Regis G
Neptuno, NCT04784559 / 2020-005951-19: Trial to Determine the Efficacy/Safety of Plitidepsin vs Control in Patients With Moderate COVID-19 Infection	Terminated	3	205	Europe, RoW	Plitidepsin, Dexamethasone, Remdesivir, Favipiravir	PharmaMar	COVID-19 Infection	03/23	03/23
NCT05052307: A Real-world Evidence Study of BNT162b2 mRNA Covid-19 Vaccine in Brazil	Completed	N/A	4574	RoW	Pfizer/BioNTech BNT162b2 mRNA COVID-19 vaccine, CoronaVac COVID-19 vaccine, ChAdOx1 nCoV-19 Covid-19 Vaccine, Ad26.COV2.S COVID-19 Vaccine	Hospital Moinhos de Vento, Universidade Federal do Paraná, Pfizer, Inova Medical	Covid19	06/22	07/23
NCT05403307: A Real-world Evidence Study of BNT162b2 mRNA Covid-19 Vaccine Among Children in Brazil	Completed	N/A	757	RoW	Pfizer/BioNTech BNT162b2 mRNA COVID-19 vaccine, CoronaVac COVID-19 vaccine	Hospital Moinhos de Vento, Universidade Federal do Paraná, Pfizer, Inova Medical	COVID-19	04/23	07/23
NCT05197647: Cohort Study for the Assessment of Long-term Impact of COVID-19 Among Mild COVID-19 Patients in Brazil	Active, not recruiting	N/A	1085	RoW	Patients with symptomatic COVID-19 disease not requiring hospitalization.	Hospital Moinhos de Vento	COVID-19, Quality of Life, Disability Physical, Disabilities Mental	12/23	07/24
NCT05165979: Cohort Study for the Assessment of Long-term Impact of COVID-19 Among Moderate and Severe COVID-19 Patients in Brazil	Active, not recruiting	N/A	650	RoW	Hospitalization due to COVID-19	Hospital Moinhos de Vento	COVID-19, Quality of Life, Disability Physical, Disabilities Mental	04/24	07/24
NCT05225194: Long-term Impact of COVID-19 Among COVID-19 Patients With Acute Respiratory Distress Syndrome in Brazil	Not yet recruiting	N/A	318	NA	COVID-19, ARDS	Hospital Moinhos de Vento	COVID-19, ARDS	11/23	11/23
Ravache, Gabriela
NCT05052307: A Real-world Evidence Study of BNT162b2 mRNA Covid-19 Vaccine in Brazil	Completed	N/A	4574	RoW	Pfizer/BioNTech BNT162b2 mRNA COVID-19 vaccine, CoronaVac COVID-19 vaccine, ChAdOx1 nCoV-19 Covid-19 Vaccine, Ad26.COV2.S COVID-19 Vaccine	Hospital Moinhos de Vento, Universidade Federal do Paraná, Pfizer, Inova Medical	Covid19	06/22	07/23
NCT05403307: A Real-world Evidence Study of BNT162b2 mRNA Covid-19 Vaccine Among Children in Brazil	Completed	N/A	757	RoW	Pfizer/BioNTech BNT162b2 mRNA COVID-19 vaccine, CoronaVac COVID-19 vaccine	Hospital Moinhos de Vento, Universidade Federal do Paraná, Pfizer, Inova Medical	COVID-19	04/23	07/23